COMBINATION OF TWO ANTIVIRAL AGENTS FOR TREATING HEPATITIS C

摘要

To provide novel methods for treating hepatitis C virus (HCV) infection, the methods avoiding side effects associated with a combination of interferon, such as peginterferon alpha, with ribavirin used in the prior art.SOLUTION: A method for treatment for the HCV comprises administering at least two direct acting antiviral agents (DAAs) to an HCV patient. Neither interferon nor ribavirin are administered to the patient during the treatment, and the treatment lasts for 8, 9, 10, 11 or 12 weeks. The at least two DAAs comprise a specific HCV protease inhibitor or a pharmaceutically acceptable salt thereof, and a specific NS5A inhibitor or a pharmaceutically acceptable salt thereof.SELECTED DRAWING: Figure 1